Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound

Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated—interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lagadic, Laurent, Katsiadaki, Ioanna, Biever, Ron, Guiney, Patrick D., Karouna-Renier, Natalie, Schwarz, Tamar, Meador, James P.
Format: Buchkapitel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 127
container_issue
container_start_page 65
container_title
container_volume 245
creator Lagadic, Laurent
Katsiadaki, Ioanna
Biever, Ron
Guiney, Patrick D.
Karouna-Renier, Natalie
Schwarz, Tamar
Meador, James P.
description Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated—interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ (PPARγ), and their heterodimers. This molecular initiating event (MIE) alters a range of reproductive, developmental, and metabolic pathways at the organism level. It is noteworthy that a variety of MeOAs have been proposed over the years for the observed endocrine-type effects of TBT; however, convincing data for the MIE was provided only recently and now several researchers have confirmed and refined the information on this MeOA. One of the most important lessons learned from years of research on TBT concerns apparent species sensitivity. Several aspects such as the rates of uptake and elimination, chemical potency, and metabolic capacity are all important for identifying the most sensitive species for a given chemical, including EDCs. For TBT, much of this was discovered by trial and error, hence important relationships and important sensitive taxa were not identified until several decades after its introduction to the environment. As recognized for many years, TBT-induced responses are known to occur at very low concentrations for molluscs, a fact that has more recently also been observed in fish species. This review explores the MeOA and effects of TBT in different species (aquatic molluscs and other invertebrates, fish, amphibians, birds, and mammals) according to the OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment (CFEDTA). The information gathered on biological effects that are relevant for populations of aquatic animals was used to construct Species Sensitivity Distributions (SSDs) based on No Observed Effect Concentrations (NOECs) and Lowest Observed Effect Concentrations (LOECs). Fish appear at the lower end of these distributions, showing that they are as sensitive as molluscs, and for some species, even more sensitive. Concentrations in the range of 1 ng/L for water exposure (10 ng/g for whole-body burden) have been shown to elicit endocrine-type responses, whereas mortality occurs at water concentrations ten times higher. Current screening and assessment methodologies as compiled in the OECD CFEDTA are able to identify TBT as a potent endocrine disruptor with a high environmental risk for the original use pattern. If those
doi_str_mv 10.1007/398_2017_8
format Book Chapter
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_springer_books_10_1007_398_2017_8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EBC6283890_27_77</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-64d9b29659ba6d3a01ae745e1b366e2dc2a47fc14aff04406482c932a8a3a7673</originalsourceid><addsrcrecordid>eNqNkU9vGjEQxZ02bUIol36Aao-5bOv_Y-eGCEkqReqh5Gx5vQbcgndr71Lx7bMIUK45zWje7z1pZhD6SvB3gjH8YFoZigkYdYFuGCMaBGZAP6ARHfpSCsE_ookGddYkuUSjwaBLoQX7jG4IpgoYkYpco0nOfzDGRCvAAFfommpCNFN8hPaLFKq-22-6EO-Kab2z0YW4Krq1L3674KPzRROLac4-54Mwj3XjUoi-uA859W0XBvl_6NaFjcVLdE3c-XgY2s0bW57ZIWDWbNumj_UX9GlpN9lPTnWMXh7mi9lT-fzr8eds-lw6BqQrJa91RbUUurKyZhYT64ELTyompae1o5bD0hFul0vMOZZcUacZtcoyCxLYGH075rZ9tfW1aVPY2rQ35xsMwO0RyIMUVz6Zqmn-ZkOwOfzCvP1iQOkpKzX_ep874w-sGzZOduPWtu18ykZSxZTGhoIBeK9JCE2x0ifTKwYAlzo</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>book_chapter</recordtype><pqid>EBC5592089_27_77</pqid></control><display><type>book_chapter</type><title>Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound</title><source>Springer Books</source><creator>Lagadic, Laurent ; Katsiadaki, Ioanna ; Biever, Ron ; Guiney, Patrick D. ; Karouna-Renier, Natalie ; Schwarz, Tamar ; Meador, James P.</creator><contributor>de Voogt, Pim</contributor><creatorcontrib>Lagadic, Laurent ; Katsiadaki, Ioanna ; Biever, Ron ; Guiney, Patrick D. ; Karouna-Renier, Natalie ; Schwarz, Tamar ; Meador, James P. ; de Voogt, Pim</creatorcontrib><description>Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated—interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ (PPARγ), and their heterodimers. This molecular initiating event (MIE) alters a range of reproductive, developmental, and metabolic pathways at the organism level. It is noteworthy that a variety of MeOAs have been proposed over the years for the observed endocrine-type effects of TBT; however, convincing data for the MIE was provided only recently and now several researchers have confirmed and refined the information on this MeOA. One of the most important lessons learned from years of research on TBT concerns apparent species sensitivity. Several aspects such as the rates of uptake and elimination, chemical potency, and metabolic capacity are all important for identifying the most sensitive species for a given chemical, including EDCs. For TBT, much of this was discovered by trial and error, hence important relationships and important sensitive taxa were not identified until several decades after its introduction to the environment. As recognized for many years, TBT-induced responses are known to occur at very low concentrations for molluscs, a fact that has more recently also been observed in fish species. This review explores the MeOA and effects of TBT in different species (aquatic molluscs and other invertebrates, fish, amphibians, birds, and mammals) according to the OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment (CFEDTA). The information gathered on biological effects that are relevant for populations of aquatic animals was used to construct Species Sensitivity Distributions (SSDs) based on No Observed Effect Concentrations (NOECs) and Lowest Observed Effect Concentrations (LOECs). Fish appear at the lower end of these distributions, showing that they are as sensitive as molluscs, and for some species, even more sensitive. Concentrations in the range of 1 ng/L for water exposure (10 ng/g for whole-body burden) have been shown to elicit endocrine-type responses, whereas mortality occurs at water concentrations ten times higher. Current screening and assessment methodologies as compiled in the OECD CFEDTA are able to identify TBT as a potent endocrine disruptor with a high environmental risk for the original use pattern. If those approaches had been available when TBT was introduced to the market, it is likely that its use would have been regulated sooner, thus avoiding the detrimental effects on marine gastropod populations and communities as documented over several decades.</description><identifier>ISSN: 0179-5953</identifier><identifier>ISBN: 9783319750361</identifier><identifier>ISBN: 3319750364</identifier><identifier>EISSN: 2197-6554</identifier><identifier>EISBN: 3319750372</identifier><identifier>EISBN: 9783319750378</identifier><identifier>DOI: 10.1007/398_2017_8</identifier><identifier>OCLC: 1028731681</identifier><identifier>OCLC: 1058972760</identifier><identifier>PMID: 29119384</identifier><identifier>LCCallNum: GE1-350GE300-350TD1-</identifier><language>eng</language><publisher>Switzerland: Springer</publisher><subject>Adverse outcome pathway (AOP) ; Amphibian ; Biocide ; Bird ; Data reliability evaluation ; Endocrine disruptor ; Fish ; Imposex ; Invertebrate ; Life-cycle studies ; Mammal ; Mechanism of action ; Molecular initiating event (MIE) ; Mollusc ; Non-monotonic dose-response ; OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment ; Peroxisome proliferator-activated receptor γ (PPARγ) ; Population-level responses ; Reproductive toxicity ; Retinoid-X receptor (RXR) ; Species sensitivity distribution (SSD) ; Tissue residue toxicity ; Tributyltin (TBT) ; Weight of evidence (WoE)</subject><ispartof>Reviews of Environmental Contamination and Toxicology Volume 245, 2018, Vol.245, p.65-127</ispartof><rights>Springer International Publishing AG 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-64d9b29659ba6d3a01ae745e1b366e2dc2a47fc14aff04406482c932a8a3a7673</citedby><relation>Reviews of Environmental Contamination and Toxicology</relation></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttps://ebookcentral.proquest.com/covers/5592089-l.jpg</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/398_2017_8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/398_2017_8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>775,776,780,789,27902,38232,41418,42487</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29119384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>de Voogt, Pim</contributor><creatorcontrib>Lagadic, Laurent</creatorcontrib><creatorcontrib>Katsiadaki, Ioanna</creatorcontrib><creatorcontrib>Biever, Ron</creatorcontrib><creatorcontrib>Guiney, Patrick D.</creatorcontrib><creatorcontrib>Karouna-Renier, Natalie</creatorcontrib><creatorcontrib>Schwarz, Tamar</creatorcontrib><creatorcontrib>Meador, James P.</creatorcontrib><title>Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound</title><title>Reviews of Environmental Contamination and Toxicology Volume 245</title><addtitle>Rev Environ Contam Toxicol</addtitle><description>Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated—interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ (PPARγ), and their heterodimers. This molecular initiating event (MIE) alters a range of reproductive, developmental, and metabolic pathways at the organism level. It is noteworthy that a variety of MeOAs have been proposed over the years for the observed endocrine-type effects of TBT; however, convincing data for the MIE was provided only recently and now several researchers have confirmed and refined the information on this MeOA. One of the most important lessons learned from years of research on TBT concerns apparent species sensitivity. Several aspects such as the rates of uptake and elimination, chemical potency, and metabolic capacity are all important for identifying the most sensitive species for a given chemical, including EDCs. For TBT, much of this was discovered by trial and error, hence important relationships and important sensitive taxa were not identified until several decades after its introduction to the environment. As recognized for many years, TBT-induced responses are known to occur at very low concentrations for molluscs, a fact that has more recently also been observed in fish species. This review explores the MeOA and effects of TBT in different species (aquatic molluscs and other invertebrates, fish, amphibians, birds, and mammals) according to the OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment (CFEDTA). The information gathered on biological effects that are relevant for populations of aquatic animals was used to construct Species Sensitivity Distributions (SSDs) based on No Observed Effect Concentrations (NOECs) and Lowest Observed Effect Concentrations (LOECs). Fish appear at the lower end of these distributions, showing that they are as sensitive as molluscs, and for some species, even more sensitive. Concentrations in the range of 1 ng/L for water exposure (10 ng/g for whole-body burden) have been shown to elicit endocrine-type responses, whereas mortality occurs at water concentrations ten times higher. Current screening and assessment methodologies as compiled in the OECD CFEDTA are able to identify TBT as a potent endocrine disruptor with a high environmental risk for the original use pattern. If those approaches had been available when TBT was introduced to the market, it is likely that its use would have been regulated sooner, thus avoiding the detrimental effects on marine gastropod populations and communities as documented over several decades.</description><subject>Adverse outcome pathway (AOP)</subject><subject>Amphibian</subject><subject>Biocide</subject><subject>Bird</subject><subject>Data reliability evaluation</subject><subject>Endocrine disruptor</subject><subject>Fish</subject><subject>Imposex</subject><subject>Invertebrate</subject><subject>Life-cycle studies</subject><subject>Mammal</subject><subject>Mechanism of action</subject><subject>Molecular initiating event (MIE)</subject><subject>Mollusc</subject><subject>Non-monotonic dose-response</subject><subject>OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment</subject><subject>Peroxisome proliferator-activated receptor γ (PPARγ)</subject><subject>Population-level responses</subject><subject>Reproductive toxicity</subject><subject>Retinoid-X receptor (RXR)</subject><subject>Species sensitivity distribution (SSD)</subject><subject>Tissue residue toxicity</subject><subject>Tributyltin (TBT)</subject><subject>Weight of evidence (WoE)</subject><issn>0179-5953</issn><issn>2197-6554</issn><isbn>9783319750361</isbn><isbn>3319750364</isbn><isbn>3319750372</isbn><isbn>9783319750378</isbn><fulltext>true</fulltext><rsrctype>book_chapter</rsrctype><creationdate>2018</creationdate><recordtype>book_chapter</recordtype><recordid>eNqNkU9vGjEQxZ02bUIol36Aao-5bOv_Y-eGCEkqReqh5Gx5vQbcgndr71Lx7bMIUK45zWje7z1pZhD6SvB3gjH8YFoZigkYdYFuGCMaBGZAP6ARHfpSCsE_ookGddYkuUSjwaBLoQX7jG4IpgoYkYpco0nOfzDGRCvAAFfommpCNFN8hPaLFKq-22-6EO-Kab2z0YW4Krq1L3674KPzRROLac4-54Mwj3XjUoi-uA859W0XBvl_6NaFjcVLdE3c-XgY2s0bW57ZIWDWbNumj_UX9GlpN9lPTnWMXh7mi9lT-fzr8eds-lw6BqQrJa91RbUUurKyZhYT64ELTyompae1o5bD0hFul0vMOZZcUacZtcoyCxLYGH075rZ9tfW1aVPY2rQ35xsMwO0RyIMUVz6Zqmn-ZkOwOfzCvP1iQOkpKzX_ep874w-sGzZOduPWtu18ykZSxZTGhoIBeK9JCE2x0ifTKwYAlzo</recordid><startdate>20180101</startdate><enddate>20180101</enddate><creator>Lagadic, Laurent</creator><creator>Katsiadaki, Ioanna</creator><creator>Biever, Ron</creator><creator>Guiney, Patrick D.</creator><creator>Karouna-Renier, Natalie</creator><creator>Schwarz, Tamar</creator><creator>Meador, James P.</creator><general>Springer</general><general>Springer International Publishing AG</general><general>Springer International Publishing</general><scope>FFUUA</scope><scope>NPM</scope></search><sort><creationdate>20180101</creationdate><title>Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound</title><author>Lagadic, Laurent ; Katsiadaki, Ioanna ; Biever, Ron ; Guiney, Patrick D. ; Karouna-Renier, Natalie ; Schwarz, Tamar ; Meador, James P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-64d9b29659ba6d3a01ae745e1b366e2dc2a47fc14aff04406482c932a8a3a7673</frbrgroupid><rsrctype>book_chapters</rsrctype><prefilter>book_chapters</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adverse outcome pathway (AOP)</topic><topic>Amphibian</topic><topic>Biocide</topic><topic>Bird</topic><topic>Data reliability evaluation</topic><topic>Endocrine disruptor</topic><topic>Fish</topic><topic>Imposex</topic><topic>Invertebrate</topic><topic>Life-cycle studies</topic><topic>Mammal</topic><topic>Mechanism of action</topic><topic>Molecular initiating event (MIE)</topic><topic>Mollusc</topic><topic>Non-monotonic dose-response</topic><topic>OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment</topic><topic>Peroxisome proliferator-activated receptor γ (PPARγ)</topic><topic>Population-level responses</topic><topic>Reproductive toxicity</topic><topic>Retinoid-X receptor (RXR)</topic><topic>Species sensitivity distribution (SSD)</topic><topic>Tissue residue toxicity</topic><topic>Tributyltin (TBT)</topic><topic>Weight of evidence (WoE)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lagadic, Laurent</creatorcontrib><creatorcontrib>Katsiadaki, Ioanna</creatorcontrib><creatorcontrib>Biever, Ron</creatorcontrib><creatorcontrib>Guiney, Patrick D.</creatorcontrib><creatorcontrib>Karouna-Renier, Natalie</creatorcontrib><creatorcontrib>Schwarz, Tamar</creatorcontrib><creatorcontrib>Meador, James P.</creatorcontrib><collection>ProQuest Ebook Central - Book Chapters - Demo use only</collection><collection>PubMed</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lagadic, Laurent</au><au>Katsiadaki, Ioanna</au><au>Biever, Ron</au><au>Guiney, Patrick D.</au><au>Karouna-Renier, Natalie</au><au>Schwarz, Tamar</au><au>Meador, James P.</au><au>de Voogt, Pim</au><format>book</format><genre>bookitem</genre><ristype>CHAP</ristype><atitle>Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound</atitle><btitle>Reviews of Environmental Contamination and Toxicology Volume 245</btitle><addtitle>Rev Environ Contam Toxicol</addtitle><seriestitle>Reviews of Environmental Contamination and Toxicology</seriestitle><date>2018-01-01</date><risdate>2018</risdate><volume>245</volume><spage>65</spage><epage>127</epage><pages>65-127</pages><issn>0179-5953</issn><eissn>2197-6554</eissn><isbn>9783319750361</isbn><isbn>3319750364</isbn><eisbn>3319750372</eisbn><eisbn>9783319750378</eisbn><abstract>Tributyltin (TBT) has been recognized as an endocrine disrupting chemical (EDC) for several decades. However, only in the last decade, was its primary endocrine mechanism of action (MeOA) elucidated—interactions with the nuclear retinoid-X receptor (RXR), peroxisome proliferator-activated receptor γ (PPARγ), and their heterodimers. This molecular initiating event (MIE) alters a range of reproductive, developmental, and metabolic pathways at the organism level. It is noteworthy that a variety of MeOAs have been proposed over the years for the observed endocrine-type effects of TBT; however, convincing data for the MIE was provided only recently and now several researchers have confirmed and refined the information on this MeOA. One of the most important lessons learned from years of research on TBT concerns apparent species sensitivity. Several aspects such as the rates of uptake and elimination, chemical potency, and metabolic capacity are all important for identifying the most sensitive species for a given chemical, including EDCs. For TBT, much of this was discovered by trial and error, hence important relationships and important sensitive taxa were not identified until several decades after its introduction to the environment. As recognized for many years, TBT-induced responses are known to occur at very low concentrations for molluscs, a fact that has more recently also been observed in fish species. This review explores the MeOA and effects of TBT in different species (aquatic molluscs and other invertebrates, fish, amphibians, birds, and mammals) according to the OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment (CFEDTA). The information gathered on biological effects that are relevant for populations of aquatic animals was used to construct Species Sensitivity Distributions (SSDs) based on No Observed Effect Concentrations (NOECs) and Lowest Observed Effect Concentrations (LOECs). Fish appear at the lower end of these distributions, showing that they are as sensitive as molluscs, and for some species, even more sensitive. Concentrations in the range of 1 ng/L for water exposure (10 ng/g for whole-body burden) have been shown to elicit endocrine-type responses, whereas mortality occurs at water concentrations ten times higher. Current screening and assessment methodologies as compiled in the OECD CFEDTA are able to identify TBT as a potent endocrine disruptor with a high environmental risk for the original use pattern. If those approaches had been available when TBT was introduced to the market, it is likely that its use would have been regulated sooner, thus avoiding the detrimental effects on marine gastropod populations and communities as documented over several decades.</abstract><cop>Switzerland</cop><pub>Springer</pub><pmid>29119384</pmid><doi>10.1007/398_2017_8</doi><oclcid>1028731681</oclcid><oclcid>1058972760</oclcid><tpages>63</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-5953
ispartof Reviews of Environmental Contamination and Toxicology Volume 245, 2018, Vol.245, p.65-127
issn 0179-5953
2197-6554
language eng
recordid cdi_springer_books_10_1007_398_2017_8
source Springer Books
subjects Adverse outcome pathway (AOP)
Amphibian
Biocide
Bird
Data reliability evaluation
Endocrine disruptor
Fish
Imposex
Invertebrate
Life-cycle studies
Mammal
Mechanism of action
Molecular initiating event (MIE)
Mollusc
Non-monotonic dose-response
OECD Conceptual Framework for Endocrine Disruptor Testing and Assessment
Peroxisome proliferator-activated receptor γ (PPARγ)
Population-level responses
Reproductive toxicity
Retinoid-X receptor (RXR)
Species sensitivity distribution (SSD)
Tissue residue toxicity
Tributyltin (TBT)
Weight of evidence (WoE)
title Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A05%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=bookitem&rft.atitle=Tributyltin:%20Advancing%20the%20Science%20on%20Assessing%20Endocrine%20Disruption%20with%20an%20Unconventional%20Endocrine-Disrupting%20Compound&rft.btitle=Reviews%20of%20Environmental%20Contamination%20and%20Toxicology%20Volume%20245&rft.au=Lagadic,%20Laurent&rft.date=2018-01-01&rft.volume=245&rft.spage=65&rft.epage=127&rft.pages=65-127&rft.issn=0179-5953&rft.eissn=2197-6554&rft.isbn=9783319750361&rft.isbn_list=3319750364&rft_id=info:doi/10.1007/398_2017_8&rft_dat=%3Cproquest_pubme%3EEBC6283890_27_77%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&rft.eisbn=3319750372&rft.eisbn_list=9783319750378&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=EBC5592089_27_77&rft_id=info:pmid/29119384&rfr_iscdi=true